Johnson M A, Chen K W, Yamamoto T. "一种的合成方法" [P]. US Patent, US 11124650 B2, 2015-04-25.
Martínez F, Johansson L, Björnsson E. "Method for the Synthesis of (3-(Pyridin-4-yl)pyrazin-2-yl)methanamine" [P]. European Patent, EP 3735555 A1, 2021-03-25.
发明人黄志刚,钱学锋,马晓峰. "A Process for Preparing High-Purity (3-(Pyridin-4-yl)pyrazin-2-yl)methanamine" [P]. 中国发明专利, 专利号 CN 109470977 B, 授权公告日 2021-04-06.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2017, 1886, (8), 8592-8602.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2012, 2122, (7), 5069-5090.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of (3-(Pyridin-4-yl)pyrazin-2-yl)methanamine Using HRMS and NMR". J. Agric. Food Chem., 2019, 983, 4864-4880.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2017, 1556, 5975-5993.